Clinical Trials Logo

Clinical Trial Summary

The LEVEL-AT Trial (LEft VEntricuLar Activation Time Shortening with Physiological Pacing vs Biventricular Resynchronization therapy: a randomized study) is a non-inferiority study that aims to determine if physiological pacing could decrease the left ventricular activation time compared with biventricular therapy.


Clinical Trial Description

To date studies have showed that physiological pacing could get similar clinical and echocardiographic response to that obtained with biventricular therapy. Activation time shortening with permanent physiological pacing has not been studied. This study will randomize 70 patients to a strategy of: biventricular pacing versus physiological pacing. LEVEL-AT study will analyze the following parameters in the 2 groups: shortening of the QRS, activation time with electrocardiographic imaging, echocardiographic asynchrony and ventricular function and clinical parameters (NYHA functional class, mortality and heart failure hospitalization). Clinical, electrocardiographic, echocardiographic and electrocardiographic imaging follow-up will be performed for 1 year. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04054895
Study type Interventional
Source Hospital Clinic of Barcelona
Contact
Status Completed
Phase N/A
Start date September 1, 2019
Completion date June 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT01996397 - Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy N/A
Active, not recruiting NCT05187611 - Conduction System Pacing vs Biventricular Resynchronization Therapy in Systolic Dysfunction and Wide QRS: CONSYST-CRT. N/A
Active, not recruiting NCT05155865 - Conduction System Pacing Versus Biventricular Pacing for Cardiac resYNChronization N/A